NM_022166.4:c.364-27488G>A
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_022166.4(XYLT1):c.364-27488G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.302 in 151,680 control chromosomes in the GnomAD database, including 7,595 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_022166.4 intron
Scores
Clinical Significance
Conservation
Publications
- Desbuquois dysplasia 2Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- Desbuquois dysplasiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- XYLT1-congenital disorder of glycosylationInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_022166.4. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.302 AC: 45833AN: 151562Hom.: 7598 Cov.: 32 show subpopulations
GnomAD4 genome AF: 0.302 AC: 45835AN: 151680Hom.: 7595 Cov.: 32 AF XY: 0.290 AC XY: 21500AN XY: 74100 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at